New Results
Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and post-marketing reports
View ORCID ProfileInes A. Smit, Avid M. Afzal, View ORCID ProfileChad H. G. Allen, View ORCID ProfileFredrik Svensson, Thierry Hanser, View ORCID ProfileAndreas Bender
doi: https://doi.org/10.1101/2020.06.12.135939
Ines A. Smit
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, Cambridge, UK
Avid M. Afzal
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, Cambridge, UK
Chad H. G. Allen
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, Cambridge, UK
Fredrik Svensson
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, Cambridge, UK
Thierry Hanser
2Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK
Andreas Bender
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, Cambridge, UK
Article usage
Posted June 13, 2020.
Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and post-marketing reports
Ines A. Smit, Avid M. Afzal, Chad H. G. Allen, Fredrik Svensson, Thierry Hanser, Andreas Bender
bioRxiv 2020.06.12.135939; doi: https://doi.org/10.1101/2020.06.12.135939
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)